Verus Capital Partners LLC Sells 6,825 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Verus Capital Partners LLC reduced its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMDFree Report) by 9.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 65,370 shares of the company’s stock after selling 6,825 shares during the period. Verus Capital Partners LLC owned 0.17% of Viemed Healthcare worth $524,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. National Bank of Canada FI boosted its position in Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after purchasing an additional 1,596 shares during the last quarter. R Squared Ltd bought a new stake in shares of Viemed Healthcare during the 4th quarter worth $41,000. PDT Partners LLC purchased a new position in shares of Viemed Healthcare in the 3rd quarter worth about $78,000. Walleye Capital LLC bought a new position in Viemed Healthcare during the third quarter valued at about $87,000. Finally, BBR Partners LLC purchased a new stake in Viemed Healthcare during the third quarter worth about $110,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $7.84 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a market cap of $305.27 million, a price-to-earnings ratio of 29.04 and a beta of 1.45. Viemed Healthcare, Inc. has a 52 week low of $6.21 and a 52 week high of $10.44. The firm’s 50-day simple moving average is $8.06 and its two-hundred day simple moving average is $8.16.

About Viemed Healthcare

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Further Reading

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.